Wasek Faisal
Wasek Faisal publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Economics and Econometrics, on topics such as Lung Cancer Diagnosis and Treatment, Global Cancer Incidence and Screening and Lung Cancer Treatments and Mutations.
- World rank
- #3,969,731 of 7,710,434 ranked researchers
- Rank in Australia
- #99,997 of 140,210
- Works
- 42
- Citations
- 326
- Citations per work
- 7.8
What does Wasek Faisal research?
Wasek Faisal's work is mostly in Medicine (56%), Economics, Econometrics and Finance (8%), Health Professions (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2661.0%
- Medicine2355.9%
- Health Professions25.1%
- Everything else1330.5%
- Social Sciences48.5%
- 1Pulmonary and Respiratory Medicine26% of their works
- 2Oncology19% of their works
- 3Economics and Econometrics8% of their works
- 4Public Health, Environmental and Occupational Health7% of their works
- 5General Health Professions5% of their works
- 6Physiology4% of their works
Research topics
- Lung Cancer Diagnosis and Treatment
- Global Cancer Incidence and Screening
- Lung Cancer Treatments and Mutations
- Health Systems, Economic Evaluations, Quality of Life
- Lung Cancer Research Studies
- Economic and Financial Impacts of Cancer
- Clinical practice guidelines implementation
- Cancer, Lipids, and Metabolism
Which keywords describe Wasek Faisal's research?
The keywords of their largest research topics: Chemotherapy, CT Screening, Lung Cancer, Clinical Trials, Targeted Therapy, Cancer Incidence, Mortality Rates and ALK Inhibitors.
- Fatty Acid Synthase
- Clinical Guidelines
- Genomic Profiles
- Cost of Care
- Cost-effectiveness Analysis
- ALK Inhibitors
- Cancer Incidence
- Clinical Trials
- CT Screening
- Chemotherapy
- Lung Cancer
- Targeted Therapy
- Mortality Rates
- EGFR Mutations
- Quality of Life
- Financial Toxicity
- Small-Cell Lung Cancer
- Guideline Development
- Lipid Metabolism
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Chemotherapy202 topics
- CT Screening161 topic
- Lung Cancer161 topic
- Clinical Trials142 topics
- Targeted Therapy142 topics
- Cancer Incidence111 topic
- Mortality Rates111 topic
- ALK Inhibitors101 topic
- EGFR Mutations101 topic
- Cost-effectiveness Analysis61 topic
- Quality of Life61 topic
- Cost of Care41 topic
- Financial Toxicity41 topic
- Genomic Profiles41 topic
- Small-Cell Lung Cancer41 topic
- Clinical Guidelines31 topic
- Guideline Development31 topic
- Fatty Acid Synthase21 topic
- Lipid Metabolism21 topic
Where does Wasek Faisal work?
Wasek Faisal's main affiliation in the publication record is Ballarat Health Services, Australia.
How many publications and citations does Wasek Faisal have?
OpenAlex counts 42 works and 326 citations for Wasek Faisal, an h-index of 8, ranking #3,969,731 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Wasek Faisal. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.